Exosens (EPA:EXENS)
39.65
-0.75 (-1.86%)
Aug 8, 2025, 5:35 PM CET
Theseus Pharmaceuticals Revenue
Exosens had revenue of 224.50M EUR in the half year ending June 30, 2025, with 79.60% growth. This brings the company's revenue in the last twelve months to 431.68M, up 22.04% year-over-year. In the year 2024, Exosens had annual revenue of 394.08M with 35.04% growth.
Revenue (ttm)
431.68M
Revenue Growth
+22.04%
P/S Ratio
4.66
Revenue / Employee
308.36K
Employees
1,401
Market Cap
2.01B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 394.08M | 102.26M | 35.04% |
Dec 31, 2023 | 291.82M | 91.07M | 45.36% |
Dec 31, 2022 | 200.75M | 34.58M | 20.81% |
Dec 31, 2021 | 166.17M | 16.31M | 10.88% |
Dec 31, 2020 | 149.86M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Airbus SE | 70.02B |
Schneider Electric S.E. | 39.32B |
Safran | 29.38B |
Vinci | 73.73B |
Compagnie de Saint-Gobain | 46.96B |
Thales | 21.35B |
Legrand | 9.21B |
Veolia Environnement | 44.60B |